Parakeet Health Builds the Patient Access Operating Layer

Parakeet Health is building a healthcare-native conversational AI platform for patient access. Founded in San Francisco in 2023, the company is led by co-founders Jung Park, Aaron Lee, and Eric Mao, who serve as CEO, CTO, and CPO.

The platform handles the administrative tripwires between patient demand and delivered care: calls that go unanswered, referrals that stall, cancellations that leave revenue on the table, and follow-ups that never happen. Parakeet operates across voice, SMS, fax, and email, integrating with electronic health record and scheduling systems instead of living beside them as another lonely dashboard.

That distinction matters now. Healthcare AI spent its first act proving that software could hold a conversation. The next act is harder and more valuable: proving it can finish the work.

About Parakeet Health

Parakeet Health describes itself as a healthcare-native, AI-native conversational platform for end-to-end patient access. Its autonomous agents book, reschedule, and cancel appointments; manage referrals; backfill cancellations; re-engage no-shows; run patient-recall campaigns; and answer operational questions around insurance, preparation, locations, and policies.

The product is designed for medical groups whose complexity has outrun the front desk. A patient interaction may touch a phone system, fax queue, scheduling database, electronic health record, provider-specific rules, and a centralized call center before an appointment is booked. Every handoff is an opportunity for delay, leakage, or an exhausted employee to inherit somebody else's mess.

Parakeet's wager is that provider organizations no longer want a point solution for each leak. They want one system accountable for the outcome.

The Patient-Access Problem Is Operational

Patient access sounds like a customer-service category until an unfilled appointment becomes lost revenue. Then the language changes quickly.

Missed calls, incomplete referrals, last-minute cancellations, and overdue recalls create the same basic failure: care demand exists, but the operating system cannot convert it into a completed appointment. Parakeet's platform monitors and acts across those moments, using practice-level rules and integrations with systems such as Epic, Cerner, athenahealth, eClinicalWorks, ModMed, and Nextech.

In a company-published outbound case study, Parakeet reported a 39% cancellation-fill rate and 14% conversion across outbound campaigns for a specialty practice with more than 150 locations. The figures are not an independent market benchmark, but they illustrate the economic target: fewer empty slots, less manual chasing, and more capacity converted into care.

This is also why the company's pay-for-performance model is strategically interesting. Parakeet says customers pay for booked appointments, resolved interactions, and call-center time saved. The model forces the pitch away from software seats and toward outcomes. Healthcare has bought enough technology that creates activity reports while employees keep doing the actual work.

Leadership Built Around Healthcare and AI

Jung Park, Parakeet's co-founder and CEO, brings more than 25 years of healthcare operating experience, including leadership roles at One Medical, Epocrates, and California Skin Institute. Co-founder and CTO Aaron Lee leads the technical organization, while co-founder and CPO Eric Mao leads product.

That mix matters because patient access is not a clean software problem. Scheduling rules vary by specialty, physician, location, insurance, procedure, and urgency. A generic voice layer can sound polished and still create operational chaos downstream. Parakeet's advantage, if it compounds, will come from understanding those rules well enough to turn conversation into completed workflow.

The founders are effectively selling two kinds of trust at once. Patients need an interaction that feels patient and competent. Provider organizations need predictable integration, escalation, compliance, and financial results. A system that wins only one side does not win the account.

Enterprise Adoption Is the Proof Point

Parakeet's October 2026 Series A announcement put numbers around its commercial momentum. The company reported 10x annual recurring revenue growth over the prior year, deployments serving more than 2,800 providers across more than 1,100 locations, and customers among six of the ten largest U.S. dermatology groups.

The company has named organizations including QualDerm Partners, Schweiger Dermatology Group, Aegis Medical Group, Genome Medical, and Pacific Coast Dermatology & Wellness Center. In September 2026, Parakeet announced a partnership with QualDerm, which supports nearly 160 practices across 17 states. The deployment focuses on finding unused appointment capacity and reconnecting patients after cancellations, missed visits, and overdue follow-ups.

Parakeet has raised $13 million in disclosed funding. Its $10 million Series A was led by Canvas Ventures, with participation from Blank Space Ventures, StoryHouse Ventures, and HMC INQ, following a $3 million seed round announced in 2024.

The capital gives Parakeet more room to expand its technology, team, personalization capabilities, enterprise deployments, and reach into additional specialties. It also raises the standard of proof. Enterprise healthcare customers do not grade on conversational charm. They grade on access, utilization, cost, revenue, and whether the system survives real-world scheduling logic.

Hiring Reveals the Next Operating Chapter

Parakeet's careers page currently lists roles for a senior software engineer, forward deployed engineer, senior customer success manager, and founding technical recruiter, all in San Francisco. That combination is more revealing than a generic promise to grow the team.

Core engineering supports platform depth. Forward-deployed engineering addresses the unglamorous but decisive work of making enterprise systems function inside customer environments. Customer success connects deployment to measurable outcomes. Recruiting capacity suggests the company expects the hiring problem itself to become an operating constraint.

Parakeet lists High Agency, No Ego, Craftsmanship, and Stay Curious as its values. The useful test will be whether those ideas survive enterprise scaling, when customization requests multiply and every customer believes its scheduling rules are a sacred text discovered on a mountain.

What Parakeet Health Signals for Healthcare AI

The healthcare AI market is moving from assistants to accountable operating systems. Transcription proved that clinicians would adopt focused AI tools. Patient access may prove whether health systems will let AI own a longer, messier chain of work across channels, departments, and financial outcomes.

Parakeet Health matters because it is choosing that harder battlefield. The company is not asking healthcare organizations to admire a clever agent. It is asking them to hand over a measurable operational function and judge the software by what gets booked, recovered, and resolved.

That is where the market is heading. The winning healthcare AI companies will not be the ones that produce the most fluent demo. They will be the ones that make the invisible machinery of care work better when nobody is watching.